Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.03.022 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Karolina Baran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantology, Immunology, Nephrology and Internal Diseases, Warsaw, Poland. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Trimethoprim, Sulfamethoxazole Drug Combination, Liver Transplantation, Pneumocystis carinii. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) is an opportunistic fungal infection that, in immunocompromised patients, can progress to respiratory failure and death. Since trimethoprim/sulfamethoxazole (TMP/SMX) chemoprophylaxis has become a standard management, the prognosis has improved. However, there are patients with a history of TMP/SMX intolerance who cannot receive chemoprophylaxis. BACKGROUND: We report on a 53-year-old male liver recipient treated with a standard triple immunosuppressive regimen in whom TMP/SMX was waived because of a history of allergy manifested as a generalized rash with edema more than 30 years ago. At transplantation, the immunologic risk was assessed as low, and liver graft function was normal. In the third month after engraftment, he developed dyspnea at rest required constant passive oxygen therapy. Ceftriaxone, azithromycin, and clindamycin were implemented. Mycophenolate acid was stopped, and tacrolimus was reduced. High-resolution computed tomography revealed interstitial pneumonia. Pneumocystis jirovecii pneumoniae was diagnosed from bronchoalveolar lavage. Instead of TMP/SMX, pentamidine and caspofungin were also used for PJP, with no improvement. After 3 weeks, the patient deteriorated. Because of his life-threatening condition, TMP/SMX was introduced in the sulfonamide desensitization protocol, including hydrocortisone and clemastinum. Within 4 days, the patient stabilized with no signs of TMP/SMX intolerance. Pneumonia subsided within a month, and TMP/SMX was prescribed lifelong. CONCLUSIONS: Prophylaxis for PJP with TMP/SMX still remains an important issue in transplant recipients. Adverse reaction to TMP/SMX in the past is not always a contraindication to reintroducing prophylaxis. The decision of prophylaxis avoidance should be analyzed carefully; in uncertain cases, a sulfonamide desensitization protocol should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Transplantology, Immunology, Nephrology and Internal Diseases, Warsaw, Poland.
- Department of Transplantology, Immunology, Nephrology and Internal Diseases, Warsaw, Poland. Electronic address: afurmanczyk@gmail.com.
Zitieren
APA
Baran, K., Furmańczyk-Zawiska, A., Wieczorek-Godlewska, R., Nitek, P., & Durlik, M. (2024). Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.03.022
Vancouver
Baran K, Furmańczyk-Zawiska A, Wieczorek-Godlewska R, Nitek P, Durlik M. Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.03.022
BibTeX
@article{Baran2024,
author = {Baran, Karolina and Furmańczyk-Zawiska, Agnieszka and Wieczorek-Godlewska, Renata and Nitek, Przemysław and Durlik, Magdalena},
title = {Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.03.022}
}
EUVIMED